**Core Concept:**
Giant cell tumor of bone (GCTB) is a benign bone tumor that primarily affects middle-aged adults, typically at the epiphyseal growth plates of long bones. It is characterized by an excessive proliferation of chondrocytes and mononuclear cells, leading to bone destruction and local bone lesions. Although most GCTBs are benign, a small percentage can become malignant.

**Why the Correct Answer is Right:**
Giant cell tumors of bone can undergo malignant change, known as malignant GCTB (mGCTB). mGCTB represents a rare subset of these tumors, accounting for approximately 5-10% of all GCTBs. The malignant form is more aggressive and has a higher potential for local recurrence and distant spread. It is crucial to differentiate mGCTB from other malignant bone tumors, such as osteosarcoma, which has a higher incidence and distinct clinical and radiological features.

**Why Each Wrong Option is Incorrect:**
A. This option is incorrect due to the low incidence of malignant change in GCTB.
B. While osteosarcoma is a malignant bone tumor, it is not related to GCTB and is a separate entity with distinct clinical and radiological features.
C. This option is incorrect as the percentage of GCTB becoming malignant is significantly less than 50%, thus not an adequate representation of the malignant variant.
D. Although some GCTBs may become malignant, the correct answer states that 5-10% of GCTBs are malignant, not the entire tumor.

**Clinical Pearl:**
Giant cell tumor of bone, despite its relatively low malignant potential, is a crucial differential diagnosis to consider when encountering a bone tumor, particularly in the epiphyseal growth plates of long bones. Understanding the clinical presentation, radiological features, and treatment strategies for both GCTB and malignant variants is essential for accurate diagnosis and patient management.